An ideal obesity treatment should minimize adipose tissue expansion and the advent of adverse metabolic consequences, which could be achieved by normalizing VEGF:VEGFR signaling. The gene discussed is KDR; the disease is obesity due to melanocortin 4 receptor deficiency.